Point of Care

With recent changes in the legalization of cannabis around the world, there is an urgent need for rapid, yet sensitive, screening devices for testing drivers and employees under the influence of cannabis at roadside and workplace

System for assessing urinary tract infections at the point of care, and determining optimal antibiotic course, is on track for initial trials in 2020

Avacta successfully generates several highly specific Affimer reagents for COVID-19 antigen rapid test ahead of schedule as part of Cytiva partnership

A new biosensor could provide another diagnostic option, as well as eventually detect viral particles in the air of crowded public spaces

Pioneering new class of diagnostic product will transform fight against pandemic

The technology behind rapid COVID-19 tests involves the use of precisely manufactured nanoparticles

Partnership to develop and manufacture a rapid test for the COVID-19 coronavirus infection for population screening

Authorization would permit medical professionals to begin using the company’s high-speed Research Use Only test system as a COVID-19 diagnostic at the point of care

Prototypes will be sent to world-leading labs in UK, Senegal, Spain, China, Malaysia, and Brazil for priority validation

New coronavirus test may be able to confirm COVID-19 in under one hour at the point of care (patient's bedside)